communityacquir
pneumonia
cap
common
ill
overal
rate
adult
approxim
case
per
person
per
year
one
main
caus
morbid
mortal
worldwid
develop
countri
cap
first
infecti
caus
mortal
mortal
within
one
year
cap
also
infecti
diseas
highest
health
cost
third
patient
need
admit
hospit
portug
hospit
admiss
rate
cap
repres
total
number
admiss
mortal
rate
previou
studi
shown
approxim
patient
admit
hospit
match
criteria
sever
cap
mortal
seem
higher
patient
pneumonia
incid
sever
diseas
increas
elderli
could
explain
age
organ
system
presenc
comorbid
cap
common
men
black
peopl
season
variat
case
occur
winter
month
concern
lower
respiratori
infect
three
entiti
differenti
cap
infect
pulmonari
parenchyma
caus
agent
acquir
commun
distinguish
nosocomi
hospit
acquir
pneumonia
hap
develop
least
h
hospit
admiss
healthcar
associ
pneumonia
hcap
occur
patient
admit
hospit
preced
day
receiv
dialyt
treatment
preced
day
resid
nurs
home
use
home
intraven
treatment
home
wound
care
close
contact
person
harbor
multidrug
resist
mdr
pathogen
last
two
entiti
higher
risk
mdr
agent
infect
sever
infect
pulmonari
parenchyma
frequent
risk
factor
acut
respiratori
distress
syndrom
ard
ard
defin
acut
onset
respiratori
failur
within
week
clinic
insult
bilater
opac
consist
pulmonari
edema
chest
radiograph
comput
tomographi
hypoxemia
pao
fio
ratio
mmhg
minimum
posit
endexpiratori
pressur
peep
continu
posit
airway
pressur
cpap
cmh
object
evid
cardiac
failur
fluid
overload
ard
categor
mild
pao
fio
moder
pao
fio
sever
pao
fio
accord
grade
hypoxemia
age
factor
associ
clinic
disord
may
impact
incid
ard
ard
associ
appreci
mortal
estim
rang
one
main
reason
hospit
admiss
cap
common
focu
infect
lead
sever
sepsi
cap
frequent
caus
viru
bacteria
although
fungi
parasit
also
etiolog
agent
context
howev
mani
case
diagnos
cap
base
clinic
radiolog
find
etiolog
defin
human
rhinoviru
influenza
viru
streptococcu
pneumonia
commonli
detect
pathogen
indirect
protect
adult
result
pediatr
adult
pneumococc
vaccin
may
potenti
contribut
slow
decreas
incid
pneumococc
infect
time
data
miss
countri
mycoplasma
pneumonia
chlamydia
pneumonia
legionella
pneumophila
also
common
often
refer
atyp
agent
agent
pneumonia
enterobacteriacea
staphylococcu
aureu
overrepres
among
sever
ill
patient
well
patient
associ
comorbid
prior
influenza
infect
antimicrobi
treatment
among
patient
requir
admiss
icu
pneumonia
commonli
detect
pathogen
also
pneumonia
frequent
caus
microorgan
smoker
particularli
invas
pneumococc
diseas
septic
shock
patient
sever
ill
influenza
pneumonia
evalu
secondari
bacteri
infect
like
caus
pneumonia
group
streptococcu
aureu
includ
commun
methicillinresist
mrsa
c
psittaci
consid
case
exposur
bird
patient
present
certain
comorbid
risk
hcap
mrsa
multidrugresist
gramneg
bacilli
consid
mrsa
import
caus
sever
occasion
necrot
cap
pneumocysti
jirovecii
possibl
agent
patient
immunodepress
human
immunodefici
viru
hiv
infect
autoimmun
diseas
transplant
immunosuppress
drug
fungal
infect
unusu
caus
cap
immunocompet
patient
certain
fungi
eg
histoplasma
capsulatum
coccidioid
spp
caus
pneumonia
patient
live
visit
endem
area
due
global
etiolog
pneumonia
nowaday
dynam
issu
evidenc
emerg
avian
influenza
virus
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
coronaviru
merscov
epidemiolog
evid
suggest
addit
pathogen
preval
virul
host
relat
factor
play
critic
role
determin
suscept
outcom
pulmonari
infect
mani
studi
sought
identifi
factor
acut
ill
capabl
predict
outcom
increas
age
sever
acut
ill
certain
preexist
medic
condit
organ
dysfunct
requir
support
emerg
admiss
icu
propos
factor
relat
increas
risk
inhospit
mortal
pneumonia
sever
index
psi
prognost
predict
system
patient
cap
also
help
guid
choic
initi
site
treatment
includ
icu
admiss
psi
score
although
score
easi
appli
emerg
depart
higher
discriminatori
power
shortterm
mortal
especi
low
risk
patient
acut
physiolog
chronic
health
evalu
apach
ii
simplifi
acut
physiolog
score
sap
ii
sepsisrel
organ
failur
assess
sofa
use
patient
admit
icu
first
two
score
admiss
score
system
last
one
repetit
score
system
apach
score
probabl
bestknown
wide
use
score
score
system
essenti
consist
two
part
sever
score
higher
number
greater
sever
condit
calcul
mortal
risk
aim
studi
understand
impact
comorbid
prognosi
sever
cap
access
clinic
analyt
paramet
sever
index
score
evolut
mortal
patient
admit
icu
chsj
infecti
diseas
servic
januari
decemb
complet
electron
medic
record
patient
admit
sever
cap
icu
januari
decemb
includ
patient
hap
hcap
exclud
previou
presenc
comorbid
chronic
diseas
noxiou
habit
medic
immunossupress
assess
document
medic
record
hiv
infect
hepat
insufficiencycirrhosi
diabet
mellitu
dm
activ
malign
neoplasia
heart
diseas
hypertens
obes
dyslipidemia
chronic
respiratori
diseas
chronic
kidney
diseas
chronic
digest
diseas
consid
chronic
diseas
current
tobacco
smoke
habit
high
level
alcohol
consumpt
g
alcohol
per
day
men
g
alcohol
per
day
women
consid
noxiou
habit
current
chemotherapi
immunossupress
drug
treatment
consid
medic
immunosuppress
patient
hiv
infect
hepat
insufficiencycirrhosi
dm
activ
malign
neoplasia
alcohol
patient
patient
medic
immunossupress
consid
immunodepress
clinic
analyt
paramet
regist
hematocrit
ht
white
blood
cell
count
platelet
number
plt
creactiv
protein
crp
albumin
alb
total
bilirubin
bil
urea
u
creatinin
cr
glucos
sodium
lactat
ph
fraction
oxygen
inspir
air
fio
partial
pressur
oxygen
pao
pao
fio
ratio
respiratori
rate
puls
temperatur
diastol
arteri
pressur
dap
systol
arteri
pressur
sap
presenc
absenc
confus
pleural
effus
first
h
icu
admiss
sever
index
calcul
patient
patient
evolut
hospit
assess
discharg
result
recuper
mortal
need
support
organ
dysfunct
like
vasopressor
support
amin
administr
invas
imv
noninvas
niv
ventilatori
support
renal
replac
therapi
rrt
extracorpor
membran
oxygen
ecmo
clinic
analyt
paramet
limit
rang
select
base
establish
sever
index
except
creactiv
protein
albumin
lactat
variabl
statist
compar
order
conclud
impact
mortal
psi
apach
ii
sap
ii
sofa
index
calcul
assess
sever
pneumonia
predict
inhospit
mortal
data
analysi
perform
use
graphpad
prism
softwar
univari
comparison
binari
variabl
conduct
mean
continu
adjust
test
continu
variabl
mannwhitney
nonparametr
twosampl
test
use
valu
normal
distribut
pvalu
consid
statist
signific
probabl
mortal
calcul
use
kaplanmei
estim
variabl
hazard
ratio
calcul
log
rank
method
confid
interv
median
surviv
defin
time
sinc
admiss
icu
death
caus
time
spent
hospit
data
regard
patient
aliv
time
analysi
censor
sever
index
icu
admiss
also
compar
use
two
statist
method
sever
index
analyz
score
compar
lowrisk
highrisk
patient
vs
median
sever
index
point
determin
median
surviv
time
mortal
risk
differ
studi
includ
patient
patient
admit
empir
treat
ceftriaxon
azithromycin
accord
hospit
protocol
patient
characterist
describ
tabl
mean
age
patient
year
old
patient
older
median
age
patient
year
old
women
men
icu
admiss
mainli
due
respiratori
insuffici
mild
ard
moder
ard
sever
ard
septic
shock
patient
one
comorbid
condit
present
patient
immunodepress
patient
mean
age
group
year
old
patient
hiv
infect
chronic
digest
diseas
smoker
mean
age
year
old
median
age
sampl
hospit
admiss
winter
march
decemb
repres
case
pneumonia
isol
present
patient
agent
found
lesser
percentag
coinfect
one
agent
found
one
patient
case
etiolog
agent
identifi
global
mortal
rate
mortal
rate
patient
ard
septic
shock
comparison
differ
sever
index
capac
predict
mortal
median
surviv
treatment
support
describ
tabl
apach
ii
psi
higher
score
significantli
predict
mortal
p
p
respect
patient
significantli
lower
median
surviv
time
day
p
day
p
respect
influenc
comorbid
mortal
median
surviv
time
patient
time
hospit
icu
admiss
time
describ
tabl
individu
comorbid
condit
show
direct
impact
mortal
icu
admiss
time
significantli
increas
obes
peopl
day
vs
day
p
smoker
day
vs
day
p
fig
median
surviv
time
increas
smoker
vs
p
patient
ckd
activ
malign
neoplasia
significantli
lower
median
surviv
time
patient
day
vs
day
p
day
vs
day
p
respect
fig
b
overal
patient
respiratori
support
need
patient
requir
intub
mechan
ventil
patient
treat
least
initi
niv
initi
niv
need
intub
mechan
ventil
dysfunct
patient
need
vasopressor
support
patient
need
renal
replac
support
refractori
hypoxemia
put
ecmo
comorbid
condit
relat
need
organ
support
case
associ
smoker
vasopressor
support
p
imv
p
compar
nonsmok
fig
b
patient
dm
need
rrt
vs
p
fig
even
though
patient
report
ckd
diagnosi
previou
admit
patient
requir
imv
higher
mortal
rate
need
ventilatori
support
need
niv
vs
p
fig
patient
start
ventil
support
niv
mortal
rate
relationship
clinic
analyt
paramet
mortal
treatment
hospit
admiss
describ
tabl
higher
mortal
rate
found
patient
crp
mgl
vs
p
ht
vs
p
cr
mgdl
vs
p
fig
fio
vs
p
show
confus
vs
p
admit
icu
need
vasopressor
support
associ
cr
mgdl
vs
p
fig
pao
fio
ratio
vs
p
presenc
pleural
effus
vs
p
patient
pao
fio
associ
greater
need
imv
vs
p
patient
admit
icu
sever
cap
mostli
men
admit
respiratori
failur
septic
shock
global
mortal
rate
confirm
data
studi
patient
ard
mortal
rate
reinforc
ard
associ
appreci
mortal
estim
rang
patient
septic
shock
admiss
mortal
rate
higher
fact
sepsi
still
consid
first
lead
caus
death
among
patient
noncoronari
medic
icu
respiratori
tract
infect
common
caus
mean
age
patient
older
although
expect
greater
frequenc
sever
diseas
elderli
mortal
rate
similar
patient
year
old
p
age
per
se
impact
prognosi
could
explain
increas
number
patient
younger
comorbid
fact
mean
age
patient
hiv
infect
andor
chronic
digest
diseas
andor
smoke
habit
lower
major
patient
one
comorbid
condit
reinforc
impact
chronic
subjac
condit
risk
factor
cap
hospit
admiss
winter
period
month
repres
case
conform
season
variat
cap
patient
etiolog
agent
isol
seen
studi
pneumonia
frequent
identifi
agent
emphas
potenti
sever
pathogen
requir
icu
admiss
present
patient
one
patient
pneumonia
coinfect
occur
reinforc
import
evalu
secondari
bacteri
infect
sever
ill
patient
influenza
pneumonia
p
jirovecci
found
patient
hiv
posit
although
incid
seem
decreas
due
antiretrovir
therapi
sinc
pneumonia
continu
one
often
isol
agent
might
import
insist
vaccin
promot
follow
cdc
recommend
vaccin
children
year
old
peopl
age
patient
comorbid
age
smoker
portugues
dg
geral
de
guidelin
recommend
univers
antipneumococc
immun
sinc
januari
children
year
old
peopl
age
older
also
consid
patient
risk
invas
pneumococc
diseas
vaccin
regardless
age
sever
sever
index
two
cap
score
three
icu
score
use
estim
inhospit
mortal
patient
classifi
high
grade
apach
ii
psi
score
significantli
higher
mortal
rate
smaller
median
surviv
time
score
show
signific
differ
high
grade
low
grade
patient
even
though
follow
tendenc
lack
abil
predict
mortal
sap
ii
sofa
score
contemporari
icu
cohort
may
reflect
need
recalibr
miss
valu
variabl
use
worst
record
paramet
h
period
regardless
treatment
inclus
glasgow
coma
scale
assess
sedat
mechan
ventil
patient
may
justifi
inaccuraci
model
also
sofa
score
design
mortal
predict
evalu
organ
dysfunct
morbid
hand
fact
apach
ii
psi
system
score
show
statist
differ
highlight
hypothesi
mortal
predict
may
relat
prior
health
condit
apart
two
score
system
sap
ii
take
prior
health
condit
consider
although
result
statist
signific
third
accur
system
predict
mortal
global
mortal
rate
sampl
approxim
time
higher
mortal
risk
estim
apach
ii
psi
score
high
score
patient
realiti
sever
index
system
accur
gener
consid
varieti
paramet
vari
among
differ
score
system
pretend
predict
likelihood
inhospit
mortal
guid
decid
initi
phase
treatment
howev
take
account
import
paramet
social
factor
perform
statu
also
select
median
score
group
patient
low
grade
high
grade
score
influenc
result
besid
help
predict
risk
inhospit
mortal
icu
score
could
also
predict
sever
need
organ
support
cardiovascular
respiratori
support
smartcop
anoth
simpl
practic
clinic
score
allow
identif
patient
sever
pneumonia
requir
icu
care
eventu
invas
ventil
vasopressor
support
studi
sever
clinic
analyt
paramet
relat
greater
mortal
need
organ
support
alreadi
consid
previou
score
except
crp
albumin
level
import
identifi
sepsi
earli
initi
prompt
measur
minim
complic
unanim
sir
criteria
sensit
suffici
specif
purpos
third
intern
consensu
definit
sepsi
recommend
qsofa
quicker
specif
way
identifi
infect
patient
outsid
icu
like
septic
greater
risk
death
prolong
intens
care
unit
stay
although
qsofa
less
accur
origin
sofa
score
requir
laboratori
test
simpler
assess
comorbid
show
individu
impact
mortal
evalu
qualit
analysi
valu
presenc
absenc
would
relev
access
comorbid
condit
futur
studi
quantifi
grade
diseas
perform
multivari
analysi
better
understand
comorbid
cumul
behavior
anoth
limit
studi
inabl
determin
symptom
durat
treatment
current
aggress
treatment
option
precoc
adequ
treatment
may
contribut
lesser
mortal
even
presenc
comorbid
hand
prolong
icu
admiss
time
obes
patient
smoker
found
previous
report
obes
besid
appar
paradox
link
obes
improv
surviv
accord
previou
studi
length
patient
stay
hospit
seem
influenc
sever
variabl
psi
score
associ
comorbid
presenc
clinic
complic
smoke
extens
studi
comorbid
known
worst
prognosi
includ
higher
mortal
rate
cohort
smoker
need
vasopressor
support
imv
patient
although
requir
longer
stay
hospit
higher
median
surviv
time
would
make
sens
studi
connect
number
cigarett
smoke
per
day
length
smoke
habit
two
comorbid
potenti
modifi
condit
lead
import
patient
inform
promot
healthi
habit
dm
associ
greater
need
rrt
probabl
due
worsen
preexist
clinic
subclin
kidney
andor
cardiovascular
diseas
although
higher
mortal
seen
patient
ckd
reach
statist
signific
p
patient
chronic
kidney
diseas
show
lower
median
surviv
time
time
hospit
similarli
happen
diabet
patient
may
reflect
greater
suscept
develop
acut
kidney
failur
acut
renal
impair
import
interfer
patient
evolut
studi
alreadi
propos
previou
studi
activ
malign
neoplasia
also
associ
lower
median
surviv
time
although
consid
risk
factor
cap
immunosuppress
gener
impact
prognosi
would
relev
develop
multivari
studi
understand
comorbid
condit
influenc
treatment
decis
imv
relat
significantli
higher
mortal
rate
confirm
result
link
ard
imv
higher
mortal
rate
although
half
patient
initi
undergo
niv
success
treat
need
intub
mechan
ventil
fact
enhanc
niv
controversi
role
sever
acut
respiratori
failur
due
cap
although
technolog
improv
ventilatori
equip
sever
clinic
analyt
paramet
significantli
relat
higher
mortal
rate
tabl
major
studi
paramet
consid
wellestablish
sever
index
system
estim
mortal
risk
except
creactiv
protein
albumin
would
relev
promot
studi
investig
predict
valu
two
specif
paramet
etiolog
diagnosi
done
patient
expect
pneumonia
common
agent
sever
cap
reinforc
import
pneumococc
vaccin
smoke
tobacco
obes
potenti
modifi
condit
associ
prolong
hospit
stay
although
associ
increas
mortal
gener
patient
need
invas
ventil
support
present
acut
renal
failur
wors
prognosi
would
advis
develop
prospect
studi
higher
number
patient
allow
multivari
analysi
quantit
character
comorbid
condit
impact
mortal
score
help
decis
guid
specif
limit
author
declar
conflict
interest
